Latest Islet cell transplantation Stories
Early attempts at islet cell transplantation to treat diabetes date to the nineteenth century, decades before the discovery of insulin in the 1930s.
In a finding that could significantly influence the way type 1 diabetes is treated, researchers at Albert Einstein College of Medicine of Yeshiva University have developed a technique for transplanting insulin-producing pancreatic cells that causes only a minimal immune response in recipients.
MINNEAPOLIS and ST. PAUL, Minn., Dec. 11 /PRNewswire/ -- The University of Minnesota has received a $40 million pledge for diabetes research from the Richard M. Schulze Family Foundation.
Kidney disease patients' ability to understand basic health information may have a significant impact on whether or not they will receive an organ transplant
Researchers identified a new source of insulin-producing cells.
Doctors have tricked mouse immune systems into thinking cells from a donor pancreas are theirs, bringing hope to diabetes patients, U.S.
HOLLYWOOD, Fla., Nov.
SAN FRANCISCO, Oct. 29 /PRNewswire/ -- Two studies presented at the annual meeting of the American Association for the Study of Liver Diseases paint a different picture of survival based on racial group for adult and child recipients of liver transplants.
DiaKine Therapeutics, a development-stage company commercializing immune modulators for the treatment of diabetes and related complications, has announced that a Phase II clinical trial with the company's lead drug candidate, Lisofylline, is underway.
DiaKine Therapeutics, developers of drugs designed to cause diabetes to go into remission, announced today that a Phase 2 Clinical Trial with the Company's lead drug candidate, Lisofylline (LSF), is underway.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.